C
Eli Lilly and Company LLY
$844.50 $30.973.81% NYSE
Recommendation
Prev Close
$813.53
Volume
6,037,167
Avg Vol (90D)
4,100,248
Market Cap
$730.33B
Dividend & Yield
$5.80(0.71%)
52-Week Range
$623.78 - $935.63
P/E (TTM)
53.16
EPS (TTM)
$15.30
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
3 Pharmaceutical Growth Stocks to Buy and Hold for 10 Years
10/23/2025 - MarketBeat
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
10/31/2025 - GuruFocus
Eli Lilly and Co (LLY) Q3 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ...
10/31/2025 - GuruFocus
Jim Cramer recaps Thursday's slate of earnings and what they signal about the economy
10/30/2025 - CNBC Television-YouTube
Meta investors think Mark Zuckerberg is living dangerously, says Jim Cramer
10/30/2025 - CNBC Television-YouTube
Q3 2025 Eli Lilly and Co Earnings Call Transcript
10/30/2025 - GuruFocus
Mizuho's Holtz talks what is behind Novo's bid for Metsera
10/30/2025 - CNBC Television-YouTube
Eli Lilly's obesity and diabetes treatments fuel growth and spark bidding war
10/30/2025 - Fast Company
Eli Lilly: The Price Upside Just Increased
10/30/2025 - SeekingAlpha
Eli Lilly: The Price Upside Just Increased
10/30/2025 - Seeking Alpha - Long Ideas
Eli Lilly and Company (NYSE:LLY) Shares Up 3.5% Following Strong Earnings
10/30/2025 - MarketBeat
Eli Lilly (LLY) Boosts Full-Year Revenue Forecast After Strong Q3 Performance
10/30/2025 - GuruFocus
US digest: Trump refugee cap sparks debate, OpenAI unveils Aardvark
10/30/2025 - Invezz News
Eli Lilly and Company (NYSE:LLY) Announces Quarterly Earnings Results
10/30/2025 - MarketBeat
Pharmaceutical Stocks To Add to Your Watchlist - October 30th
10/30/2025 - MarketBeat
Medical Stocks To Watch Now - October 30th
10/30/2025 - MarketBeat
Eli Lilly (LLY) Stock Trades Up, Here Is Why
10/30/2025 - StockStory Articles
Thursday links: meaning through motion
10/30/2025 - Abnormal Returns
We're raising our Eli Lilly price target what a difference a quarter makes
10/30/2025 - CNBC: Healthcare
Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales
10/30/2025 - Zacks Investment Research
Average long-term US mortgage rate dips to 6.17%, its lowest level in more than a year
10/30/2025 - Orange County Register: Business
Eli Lilly says weight-loss pill a candidate for speedy approval under new US program
10/30/2025 - Yahoo! Finance: News
Banks and retailers run short on pennies as the US Mint stops making them
10/30/2025 - Orange County Register: Business
Eli Lilly Stock Rises -- Blowout Earnings Smash Forecasts, Lifts 2025 Outlook
10/30/2025 - GuruFocus
Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
10/21/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$53.26B
EBITDA (TTM)
$24.78B
EBIT (TTM)
$22.88B
Net Income (TTM)
$13.80B
Balance Sheet
Total Assets (Q)
$100.92B
Total Debt (Q)
$39.98B
Total Liabilities (Q)
$82.57B
Book Value Per Share (Q)
$20.37
Cash Flow
Cash from Operations (TTM)
$10.94B
Cash from Investing (TTM)
-$11.11B
Cash from Financing (TTM)
$120.70M
Net Change in Cash (TTM)
$152.30M
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Oct 27 and 31 (est)
Price History
Loading...
Beta
0.86
7-Day Total Return
5.62%
30-Day Total Return
10.69%
60-Day Total Return
13.18%
90-Day Total Return
8.56%
Year to Date Total Return
8.59%
1-Year Total Return
-0.28%
2-Year Total Return
49.99%
3-Year Total Return
136.62%
5-Year Total Return
578.87%
52-week Low
Aug 08, 2025 - $623.78
52-week High
Mar 03, 2025 - $935.63
Valuation
Market Cap
$730.33B - Mega Cap
Enterprise Value
$766.43B
Price/Sales (TTM)
13.74
Price/Book (Q)
39.93
Dividends and Shares
Shares Outstanding
899.80
Dividend Per Share (Most Recent)
$1.50
Dividend Per Share (TTM)
$5.80
Corporate Info
Website
www.lilly.com
Phone Number
317 276 2000
Address
Lilly Corporate Center
Indianapolis, IN 46285
Country
United States
Year Founded
1876
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix... more
NYSE 10/30/2025 4:00PM Eastern Quotes delayed